The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, involves a complex complicated synthetic process. Initial routes focused on protein section coupling, utilizing solid-phase https://denismewx166706.oblogation.com/39596401/synthesis-and-research-applications-of-retatrutide